Browse > Article
http://dx.doi.org/10.4332/KJHPA.2020.30.2.164

Implications of Price Setting Strategies for New Health Technologies from Five Countries  

Chung, Seol-hee (HIRA Research Institute, Health Insurance Review and Assessment Service)
Kwon, Ohtak (HIRA Research Institute, Health Insurance Review and Assessment Service)
Choi, Yeonmi (HIRA Research Institute, Health Insurance Review and Assessment Service)
Moon, Kyeongjun (HIRA Research Institute, Health Insurance Review and Assessment Service)
Chae, Jungmi (HIRA Research Institute, Health Insurance Review and Assessment Service)
Lee, Ruri (HIRA Research Institute, Health Insurance Review and Assessment Service)
Publication Information
Health Policy and Management / v.30, no.2, 2020 , pp. 164-177 More about this Journal
Abstract
This study aims to compare the experience of selected countries in operating separate payment system for new healthcare technology and to find implications for price setting in Korea. We analyzed the related reports, papers, laws, regulations, and related agencies' online materials from five selected countries including the United States, Japan, Taiwan, Germany, and France. Each country has its own additional payment system for new technologies: transitional pass-through payment and new technology ambulatory payment classification for outpatient care and new technology add-on payment for inpatient care (USA), an extra payment for materials with new functions or new treatment (C1, C2; Japan), an additional payment system for new special treatment materials (Taiwan), a short-term extra funding for new diagnosis and treatment (NUB; Germany), and list of additional payments for new medical devices (France). The technology should be proven safe and effective in order to get approval for an additional payment. The price is determined by considering the actual cost of providing the technology and the cost of existing similar technologies listed in the benefits package. The revision cycle of the additional payment is 1 to 4 years. The cost or usage is monitored during that period and then integrated into the existing fee schedule or removed from the list. We conclude that it is important to set the explicit criteria to select services eligible for additional payment, to collect and analyze data to assess eligibility and to set the payment, to monitor the usage or cost, and to make follow-up measures in price setting for new health technologies in Korea.
Keywords
New healthcare technology; Reimbursement; Additional payment; Price setting; National Health Insurance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Office of Technology Assessment. Assessing the efficacy and safety of medical technologies. Washington (DC): U.S. Government Printing Office; 1978.
2 National Health Insurance Administration, Ministry of Health and Welfare. 2017-2018 National health insurance annual report. Taipei: Ministry of Health and Welfare; 2017.
3 National Health Insurance Administration, Ministry of Health and Welfare. Guidelines for national health insurance Tw-DRGs ver. 4.0. Taipei: Ministry of Health and Welfare; 2016.
4 Ministry of Health, Labour and Welfare in Japan. About combination of insurance and non-insurance medical treatment [Internet]. Tokyo: Ministry of Health, Labour and Welfare in Japan; 2019 [cited 2019 Oct 29]. Available from: https://www.mhlw.go.jp/topics/bukyoku/isei/sensiniryo/heiyou.html.
5 Chernew ME, Newhouse JP. Health care spending growth. In: Pauly MV, McGuire TG, Barros PP, editors. Handbook of health economics: volume 2. Amsterdam: Elsevier; 2012. pp. 1-4.
6 Organization for Economic Cooperation and Development. New health technologies: managing access, value and sustainability. Paris: OECD Publishing; 2017.
7 The Principles on the Patients' Payment for the Difference between the Maximum Amount Paid by Insurer for the Special Material and the Maximum Amount Charged by Contracted Medical Care Institutions (Taiwan), (Jun 11, 2014).
8 Ministry of Health and Welfare. TW-DRGs improve healthcare quality, efficiency and fairness [Internet]. Taipei: Ministry of Health and Welfare; 2017 [cited 2019 May 8]. Available from: mohw.gov.tw/cp-115-2552.html.
9 Tw-DRG Payment Rule (amendment, Taiwan), (July 4, 2014).
10 National Health Insurance Act (Taiwan), Law No. 10600142271 (Nov 29, 2017).
11 Obermann K, Muller P, Muller HH, Schmidt B, Glazinski B. Understanding the German health care system. Heidelberg: Mannheim Institute of Public Health, Heidelberg University; 2012.
12 AiM. Reimbursement of medical devices in Germany. Berlin: IGES; 2019.
13 Henschke C, Baumler M, Weid S, Gaskins M, Busse R. Extrabudgetary ('NUB') payments: a gateway for introducing new medical devices into the German inpatient reimbursement system? J Manag Market Healthc 2010;3(2):119-133. DOI: https://doi.org/10.1179/175330310x12665793931221.   DOI
14 Ministry of Health and Welfare; Korea Centers for Disease Control and Prevention; Ministry of Food and Drug Safety. Policy for regulatory reform for the medical devices: implementation task, to be completed by the end of this year. Sejong: Ministry of Health and Welfare; 2019.
15 Ministry of Health and Welfare. National health insurance coverage expansion plan. Sejong: Ministry of Health and Welfare; 2017.
16 Ministry of Health and Welfare; Ministry of Food and Drug Safety. The government launches system reform to promote high-tech medical device industry. Sejong: Ministry of Health and Welfare; 2017.
17 Ministry of Health and Welfare; Ministry of Science and ICT; Ministry of Trade, Industry and Energy; Ministry of Food and Drug Safety. The government will overhaul the regulations on the certification and approval of the medical devices. Sejong: Ministry of Health and Welfare; 2018.
18 Kwon OT, Chung SH, Chae JM, Choi YM, Moon KJ, Lee LR. The assessment of the appropriateness of adopting robot-assisted surgery in the national health insurance coverage. Wonju: Health Insurance and Review Assessment Service; 2019.
19 Kim JU, Lee EK, Shin CM, Lee WS, Ko RJ, Yoon JH, et al. A study on the introduction of the new assessment method for innovative health technologies. Seoul: National Evidence-based Healthcare Collaborating Agency; 2018.
20 Cho SJ, Kim SJ, Choi YM, Lee DK. Assessment for the coverage of innovative health technology. Wonju: Health Insurance and Review Assessment Service; 2018.
21 Embassy of the Republic of Korea in France. Present status and reform of social security system in France. Paris: Embassy of the Republic of Korea in France; 2017.
22 Busse R, Blumel M. Germany: health system review. Copenhagen: WHO Regional Office for Europe; 2014.
23 Inbar A. A shortcut to medical device reimbursement in Germany. London: MEDIClever; 2010.
24 Busse R, Geissler A, Quentin W, Wiley M. Diagnosis-related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire: McGraw-Hill, Open University Press; 2011.
25 Ministry of Solidarity and Health. La liste en sus [Internet]. Paris: Ministry of Solidarity and Health [cited 2019 Aug 29]. Available from: https://solidarites-sante.gouv.fr/soins-et-maladies/autresproduits-de-sante/dispositifs-medicaux/la-liste-en-sus.
26 Choi KC, Shon DK, Hong SM, Lee SY, Jo JY. Present status and reform of health security system in major countries: France. Wonju: National Health Insurance Service; 2014.
27 Jo YY, Kim SH. A study on improvement of private health insurance management system. Seoul: Korea Insurance Research Institute; 2008.
28 Ministry of Solidarity and Health. Innovation package [Internet]. Paris: Ministry of Solidarity and Health; 2019 [cited 2019 Aug 29]. Available from: https://solidarites-sante.gouv.fr/system-de-santeet-medico-social/recherche-et-innovation/forfait-innovation.
29 French National Authority for Health (HAS). Medical device assessment in France guidebook. Saint-Denis: French National Authority for Health (HAS); 2009.
30 Bae SY, Yang DH, Jang YJ, Kim JY, Kim HR, Park JH. Study on reassessment of medical device. Wonju: Health Insurance Review and Assessment Service, Inje University; 2018.
31 Borisenko O, Schaffner I. Innovative payment schemes for medical technologies and in-vitro diagnostic tests in Europe. Brussels: MedTec Europe; 2018.
32 Do KY, Park SH, Choi JI, Kim SJ, Sun WJ, Kim CL, et al. The guidelines to evaluate appropriateness for the coverage of the national health insurance for the AI based medical technologies. Wonju: Health Insurance and Review Assessment Service, The Korean Society of Radiology; 2018.
33 Kim NK, Ko BS, Lee HN, Kwon ES, Lee YI, Ok JH. The guidelines to evaluate appropriateness for the coverage of the national health insurance for the 3D printing in medicine. Seoul: Health Insurance and Review Assessment Service, The Korean Society of 3D Printing in Medicine; 2018.
34 Chung SH, Kwon OT, Choi YM, Moon KJ, Chae JM, Lee R. The health system to provide universal coverage and the payment system for new technology: United States, Japan, Taiwan, Germany, France and Australia. Wonju: Health Insurance Review & Assessment Service; 2019.
35 Hernandez J, Machacz SF, Robinson JC. US hospital payment adjustments for innovative technology lag behind those in Germany, France, and Japan. Health Aff (Millwood) 2015;34(2):261-270. DOI: https://doi.org/10.1377/hlthaff.2014.1017.   DOI
36 Park EC, Lee HJ, Kim JY, Sam JY, Choi JW, Jeon SY, et al. A study on the improvement of new health technology assessment system for patient safety and early adoption of new technology. Sejong: Ministry of Health and Welfare, Yonsei University; 2016.
37 Preker AS, Haslinger RR, Busse R, Rosenmoller M. Stewardship, governance, and management. In: Preker AS, Liu X, Velenyi EV, Baris E, editors. Public ends, private means: strategic purchasing of health services. Washington (DC): The World Bank; 2007. pp. 125-148.
38 Tsintzos S, Holtorf A. Germany-medical devices: global health technology assessment roadmap. Lawrenceville (NJ): ISPOR; 2011.
39 HTAi. HTAi glossary: new health technology [Internet]. Alberta: HTAi; 2019 [cited 2019 Sep 25]. Available from: htaglossary.net/new+health+technology.
40 Rules on New Technology Assessment, Ordinance of the Ministry of Health and Welfare No. 353 (Sep 21, 2015).
41 Centers for Medicare & Medicaid Services. Application for new medical services and technologies seeking to qualify for add-on payments under the hospital inpatient prospective payment system for federal fiscal year (FY) 2020 [Internet]. Baltimore (MD): Centers for Medicare & Medicaid Services; 2019 [cited 2019 May 23]. Available from: https://www.cms.gov/Medicare-fee-for-Service-Payment/Acute-InpatientPPS/newtech.html.
42 Barber SL, Lorenzoni L, Ong P. Price setting and price regulation in health care: lessons for advancing universal health coverage. Geneva: World Health Organization, Organization for Economic Cooperation and Development; 2019.
43 MedPAC. Payment basics. Washington (DC): Medicare Payment Advisory Commission; 2019.
44 Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services. 42 CFR ch. IV (10-1-12 edition):412.87: additional payment for new medical services and technologies: general provisions; 412.88 additional payment for new medical service or technology [Internet]. Washington (DC): U.S. Government Publishing Office; 2009 [cited 2019 May 23]. Available from: https://www.govinfo.gov/content/pkg/CFR-2012-title42-vol2/pdf/ CFR-2012-title42-vol2-sec412-87.pdf.
45 MedPAC. Hospital acute inpatient services payment system: payment basics. Washington (DC): Medicare Payment Advisory Commission; 2018.
46 MedPAC. Report to the Congress: Medicare payment policy. Washington (DC): Medicare Payment Advisory Commission; 2003.
47 Centers for Medicare & Medicaid Services. New medical services and new technologies [Internet]. Baltimore (MD): Centers for Medicare & Medicaid Services; 2019 [cited 2019 May 8]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service- Payment/AcuteInpatientPPS/newtech.htms.
48 Centers for Medicare & Medicaid Services, U.S. Department ofHealth and Human Services. 42 CFR ch. IV (10-1-12 edition):419.66: transitional pass-through payments: medical devices[Internet]. Washington (DC): U.S. Government Publishing Office;2014 [cited 2019 May 23]. Available from: https://www.govinfo.gov/content/pkg/CFR-2014-title42-vol3/pdf/CFR-2014-title42-vol3-sec419-66.pdf.
49 MedPAC. Outpatient hospital services payment system: payment basics. Washington (DC): Medicare Payment Advisory Commission; 2018.
50 MedPAC. Report to the Congress: Medicare and the health care delivery system. Washington (DC): Medicare Payment Advisory Commission; 2017.
51 Centers for Medicare & Medicaid Services, U.S. Department ofHealth and Human Services. 442 CFR ch. IV (10-1-12 edition):419.64: transitional pass-through payments: Drugs and biologicals[Internet]. Washington (DC): U.S. Government Publishing Office;2009 [cited 2019 May 23]. Available from: https://www.govinfo.gov/content/pkg/CFR-2012-title42-vol3/pdf/CFR-2012-title42-vol3-sec419-64.pdf.
52 MedPAC. Payment basics: ambulatory surgical center services payment system. Washington (DC): Medicare Payment Advisory Commission; 2018.
53 Centers for Medicare & Medicaid Services. Process and information required for a new technology ambulatory payment classification (APC) assignment under the hospital outpatient prospective payment system (OPPS). Baltimore (MD): Centers for Medicare & Medicaid Services; 2018.
54 Bae JH, Kim GG, Kim MJ, Moon SH, Lim HJ, Seonwoo D, et al. Japan's social security system. Sejong: Korea Institute for Health and Social Affairs, Nanam Publishers; 2018.
55 Kim DH, Kwon JH, You EJ, Moon YP. Current states and trends of health insurance system in Japan. Health Insur Policy 2015;15(2):235-255.
56 Ministry of Health, Labour and Welfare in Japan. 2016 Guidebook on insurance coverage for medical equipment, commissioned by the Ministry of Health, Labor and Welfare [Internet]. Tokyo: Ministry of Health, Labour and Welfare in Japan; 2017 [cited 2019 Oct 29]. Available from: https://www.mhlw.go.jp/file/06-Seisakujouhou-10800000-Iseikyoku/0000176118.pdf.
57 Ministry of Health, Labour and Welfare in Japan. Overview and basic concept of DPC system (DPC/PDPS) [Internet]. Tokyo: Ministry of Health, Labour and Welfare in Japan; 2011 [cited 2019 Sep 3]. Available from: https://www.mhlw.go.jp/stf/shingi/2r985200000105vxatt/2r98520000010612.pdf.
58 Ministry of Health, Labour and Welfare in Japan. About non-insurance combination medical treatment system [Internet]. Tokyo: Ministry of Health, Labour and Welfare in Japan; 2006 [cited 2019 Oct 29]. Available from: https://www.mhlw.go.jp/file/06-Seisakujouhou- 12400000-Hokenkyoku/20170925.pdf.
59 Law to Revise a Part of the Health Insurance Act in Japan, Law No. 83 (Oct 1, 2006).
60 Ministry of Health, Labour and Welfare in Japan. About reform in national health insurance system [Internet]. Tokyo: Ministry of Health, Labour and Welfare in Japan; 2019 [cited 2019 Oct 29]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/shakaihoshou/hokenseido_kaikaku.html.
61 National Health Insurance Medical Expenses Payment Agreement Committee. National health insurance total medical expenses payment system: question and answer. Taipei: National Health Insurance Medical Expenses Payment Agreement Committee; 2015.